"The Untold Story of How High-Quality and Low-Cost Drugs Were Incorporated Into PEPFAR" in the current issue of the Annals

Read More +
  • HCV Drug Development Advisory Group (HCV DrAG): A Video Overview Read more »
  • Read about the 2013 Washington Area Interns Networking Day Read more »
  • Watch Video from the 2012 National Summit on HIV and Viral Hepatitis Diagnosis, Prevention and Access to Care Read More +
  • Representative Henry Waxman - Recipient of the 2012 C. Everett Koop HIV/AIDS Public Health Leadership Award Read More +

Current and Recent Projects

  • June 17, 2014

    The Forum HIV Cure Research Project will convene a series of meetings to address the clinical trial and regulatory issues surrounding HIV cure research. Focusing on the ethical, regulatory and clinical factors of HIV cure research, the project will utilize the traditional Forum approach of engaging key stakeholders, including those from the FDA, NIH, academia, advocates, and industry.

  • April 01, 2014

    The HCV Drug Development Advisory Group (DrAG) is a unique forum that brings together representatives from the U.S. and European regulatory agencies, academia, patient advocates and the pharmaceutical industry to build consensus around drug development-related issues. This Q&A video series features the reflections of several DrAG members on the impact the group has had on HCV drug development.

  • March 31, 2014

    With a number of first-line regimen drug patents expiring in the next few years, the availability of generic antiretrovirals (ARVs) will be an unprecedented occurrence in the history of the treatment of HIV infection. Recent studies have demonstrated that a 3-pill, generic-based regimen (two generics, one branded) has the potential for significant price reductions. However, patients and providers have expressed concerns about potential consequences including: 1) increased pill burden, 2) decreased treatment adherence, and 3) the quality of generic drugs.

Upcoming Events

  • Judith Aberg, MD, Professor of Medicine and Chief, Infectious Diseases, Icahn School of Medicine at Mount Sinai
  • David Anderson, MD, Senior Medical Director, Janssen Services, LLC
  • Cornelius Baker, BA, National Policy Advisor; Senior Communications Advisor, National Black Gay Men's Advocacy Coalition; FHI 360
  • John G. Bartlett, MD, Professor Emeritus, Johns Hopkins University School of Medicine
  • Carol Brosgart, MD, Clinical Professor, University of California, San Francisco
  • Victoria Cargill, MD, MSCE, Director of Minority Research & Clinical Studies, National Institutes of Health
  • Gavin Cloherty, PhD, Associate Director, Global Scientific Affairs, Abbott Molecular
  • Judith Currier, MD, MSc, Professor of Medicine & Division Head of ID, David Geffen School of Medicine, UCLA
  • Victor DeGruttola, ScD, Professor & Chair, Division of Biostatistics, Harvard School of Public Health
  • Carl Dieffenbach, PhD, Director, DAIDS, National Institute of Allergy and Infectious Diseases
  • Stephan Dressler, MD, PhD, EATG Representative, European AIDS Treatment Group
  • David Evans, Director of Research Advocacy, Project Inform
  • Christopher Gordon, PhD, Branch Chief, National Institute of Mental Health
  • Heather Hauck, LICSW, MSW, Director, Division of State HIV/AIDS Programs, Health Resources and Services Administration
  • TBD, International AIDS Society
  • Gabrielle Heilek, PhD, Director, Clinical Research, Roche Molecular Systems
  • Angel Hernandez, ACTG Community Representative, AIDS Clinical Trials Group
  • Sally Hodder, MD, Executive Vice-chair, Department of Medicine; Director of HIV Services, Rutgers New Jersey Medical School, University Hospital
  • King Holmes, MD, PhD, Professor of Medicine/Global Health; Head, Center for AIDS and STD, University of Washington; Harborview Medical Center
  • Michael Horberg, MD, MAS, FACP, Executive Director of Research, Mid-Atlantic Permanente Medical Group, Kaiser Permanente
  • William Hunt, MS, Marketing Director, Celera Corporation
  • Filip Josephson, MD, PhD, Clinical Assessor, Swedish Medical Products Agency; European Medicines Agency
  • Amy Keller, Program Manager-Consultant, Forum for Collaborative HIV Research
  • Scott Kellerman, MD, MPH, Principal Technical Advisor for HIV Prevention, Management Sciences for Health
  • Michael Lederman, MD, Scott R. Inkley Professor of Medicine, Case Western Reserve University School of Medicine, University Hospital
  • Sandra Nusinoff Lehrman, MD, Global Director, Scientific Affairs - Antivirals, Merck Research Laboratories
  • Christine Lubinski, Vice-President for Global Health, Center for Global Health Policy, , Infectious Diseases Society of America
  • Kenneth Mayer, MD, Medical Research Director; Director of HIV Prevention; Visiting Professor of Medicine, The Fenway Institute; Beth Israel Deaconess Medical Center; Harvard Medical School
  • Veronica Miller, PhD, Executive Director, Forum for Collaborative HIV Research
  • Jacques Normand, PhD, Director of AIDS Research, National Institute on Drug Abuse
  • Jean-Michel Pawlotsky, MD, PhD, Professor, Hopital Henri Mondor
  • Dwight Peavy, Executive Director, Newark EMA
  • Chris Petropoulos, PhD, Chief Scientific Officer, Monogram Biosciences
  • Arthur Reingold, MD, Professor and Associate Dean for Research, University of California, Berkeley School of Public Health
  • Boris Renjifo, MD, PhD, Associate Medical Director, Virology, abbVie
  • James Rooney, MD, Vice President of Medical Affairs, Gilead Sciences, Inc.
  • David Ross, MD, PhD, Director, Clinical Public Health Programs, Veterans Health Administration
  • Anna Laura Ross, PhD, Head of International Affairs and Scientific Relations, French National Agency for Research on AIDS and Viral Hepatitis (ANRS)
  • Caroline Ryan, MD, MPH, Chief Technical Officer, US Department of State
  • Jeffrey Schouten, MD, JD, Director, Office of HIV/AIDS Network Coordination
  • Daniel Seekins, MD, Group Medical Director,HIV Medical Strategy, Bristol-Myers Squibb
  • Kimberly Y. Smith, MD, MPH, Vice President, Global Medical Strategy, ViiV Healthcare
  • David Stanton, MN, MPH, Chief, Division of Technical Leadership, US Agency for International Development
  • Kimberly Struble, PharmD, Medical Team Leader, Food and Drug Administration
  • Ronald Valdiserri, MD, MPH, Dep. Assistant Secretary for Health, Infectious Diseases, Department of Health and Human Services
  • Linda Valleroy, PhD, Associate Director for Science, Centers for Disease Control and Prevention
  • Prasad Velisetty, MD, Senior Medical Director, Quintiles Global CRO
  • David Williams, MBA, Principal, MedPharma Partners LLC

The current major pharmaceutical industry sponsors to the Forum Executive Committee are:












Project-specific sponsors are listed on individual project pages